A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
- Status
- planned
- Phase
- Phase 3
- Institution
- VA Office of Research and Development
- Principal investigator
- Lori Lynne Davis, MD AB
- Start date
- 2026-07-30
- End date
- 2031-06-30
- Registry ID
- NCT07226232
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.